The Role of the Mohs Surgeon on Interdisciplinary Care Teams for Patients with Advanced Non-Melanoma Skin Cancers

Friday, October 7, 2022

9:45 PM – 10:45 PM ET

8:45 PM – 9:45 PM CT

7:45 PM – 8:45 PM MT

6:45 PM – 7:45 PM PT


  • Whiteboard and 2D animations
  • Interactive, case-based learning environment
  • Create your own Personalized Poster

Learning Objectives

After completing the CME activity, learners should be better able to:
  • Interpret data supporting the use of new systemic therapies for the treatment of patients with advanced NMSCs failing or not amenable to surgery or radiation
  • Select patients with unresectable NMSCs who may derive greater benefit from new systemic therapies as opposed to Mohs surgery
  • Cultivate close working relationships with other members of interdisciplinary care teams for the management of patients with advanced NMSCs failing or not amenable to surgery or radiation

Target Audience

This CME initiative is designed to meet the educational needs of surgical dermatologists, Mohs surgeons, dermatologists and other healthcare practitioners who care for patients with advanced/mBCC or CSCC.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity was planned and produced in accordance with ACCME Essentials.

Credit Designation Statement

Med Learning Group designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosure Of Unlabeled Use

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.


Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at:


Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at

Feel free to pass on this invitation to physicians, fellows, physician assistants, nurses, other health care practitioners, and any other colleagues you believe would be interested in attending this free program.

Release date: October 7, 2022
Expiration date: October 7, 2023
Estimated time to completion: 1.0 hour